TITLE

The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe

AUTHOR(S)
Lançon, Christophe; Toumi, Mondher; Sapin, Christophe; Hansen, Karina
PUB. DATE
January 2008
SOURCE
BMC Psychiatry;2008, Vol. 8, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: After sertindole's suspension, health authorities established a specific named-patient use (NPU) programme in order to supply sertindole to patients who did not respond to or did not tolerate alternative treatments. This programme provided the possibility of prospectively following an exhaustive cohort of patients treated with sertindole after its suspension. A survey was performed to assess sertindole's modalities of prescription, assess and document any serious adverse events (SAEs), and assess the mortality rate within the NPU cohort. Methods: The study comprised a survey of sertindole-treated patients in eleven European countries. All patients treated with sertindole within the NPU programme were eligible for the study. Results: 1,432 patients were included in the study. The reason for sertindole prescription was lack of efficacy (approximately 50%) or adverse events (approximately 20%) of other antipsychotic treatments. The mean sertindole dose was 13.4 mg daily. Lack of efficacy and adverse events were reported as reasons for sertindole discontinuation. A total of 97 SAEs were recorded, including ten fatal outcomes, which occurred during the study period or within thirty days after sertindole discontinuation. The all-cause mortality rate was 0.51 per 100 Person-Years of Exposure (95% Poisson confidence interval: 0.23-0.97). QTc prolongation was reported in 15 patients (1.05% of total patients), being a rate of 0.85 per 100 Person-Years of Exposure [95% CI: 0.48-1.41]. Conclusion: Although prescribing and supplying sertindole were subject to administrative constraints, a significant number of patients were treated with sertindole, thus supporting the need for sertindole in specific cases. Trial registration number: Not applicable.
ACCESSION #
35702814

 

Related Articles

  • Opioid use − multiple concerns.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p4 

    The article reports on several studies regarding opioid use in the U.S. According to the results of a U.S. study, opioids should not be prescribed for adolescents with headache. Another U.S. study revealed that high-risk use of prescription opioids is associated with increased overdose...

  • FIRST STOP: YOUR CLINIC.  // Getting the Most from Your Medications;2002, p8 

    The article discusses the management of medication. Get both the brand name and the generic name in writing. Update this record at least once a year, especially if you're seeing more than one doctor. If you're planning any kind of surgery (including dental surgery), give your doctor or...

  • Postmarketing surveillance of adverse reactions to drugs. Rawlins, Michael D. // British Medical Journal (Clinical Research Edition);3/24/1984, Vol. 288 Issue 6421, p879 

    Presents the postmarketing surveillance of adverse reactions to drugs in Great Britain. Occurrence of iatrogenic diseases; Implementation of the yellow card system; Examination of mortality and morbidity statistics.

  • Pharmacology. Blockman, Mark; Cohen, Karen // CME: Continuing Medical Education;Jun2011, Vol. 29 Issue 6, p229 

    An introduction to the journal is presented in which the editors discuss various reports published within the issue including the role of adverse drug reactions (ADR) to morbidity and mortality of South African patients, quantifying risks and benefits of medicines, and a review of cutaneous ADR.

  • Drug Use Issues and Actions.  // Formulary;Mar2001, Vol. 36 Issue 3, p234 

    Presents news concerning medication use in the United States as of March 2001. Uses of adverse drug reaction data; Effect of extending the dosing interval of prophylactic IV acyclovir; Prevention strategies for specific medications.

  • Different ways to spell relief. Jaroff, Leon; Mondi, Lawrence // Time;11/6/1995, Vol. 146 Issue 19, p58 

    Compares the new over-the-counter medications that treat heartburn with the older methods. Workings of acid blockers such as Pepcid and Tagamet; The antacids' affect; Side effects of H2 blockers and antacids.

  • Frequency, types and severity of medication use-related problems among medical outpatients in Nigeria. Yusuff, Kazeem B.; Tayo, Fola // International Journal of Clinical Pharmacy;Jun2011, Vol. 33 Issue 3, p558 

    Objectives To determine the frequency, types and severity of medications use-related problems among medical outpatients in a tertiary care setting in southwestern Nigeria. Setting Medical outpatient clinics of a 900-bed Teaching Hospital located in Ibadan, Southwestern Nigeria. Methods A...

  • Reduction of Digoxin Toxicity Associated with Measurement of Serum Levels. Duhme, David W.; Greenblatt, David J.; Koch-Weser, Jan // Annals of Internal Medicine;Apr74, Vol. 80 Issue 4, p516 

    Presents a study which monitored adverse reactions to digoxin in hospitalized medical patients in a drug surveillance program in Boston, Massachusetts. Comparison of the correlation of the intensity of action of most drugs with their concentration in the serum and their dosage; Frequency of...

  • Headaches over painkillers. Sweet, Melissa // Bulletin with Newsweek;04/11/2000, Vol. 118 Issue 6219, p52 

    Highlights the importance of developing better post-marketing surveillance of drugs in Australia. Adverse reactions of drugs; Major problem with clinical trials; International concern about the use on children of drugs that have been tested only on adults.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics